Latest News Eye Health America Adds an MD and an OD to Board By Staff Wednesday, October 9, 2019 12:15 AM Dr. Joseph Parisi Dr. Scott HanATLANTA—Eye Health America (EHA), an eyecare practice management company, has named two new board members: ophthalmologist Dr. Joseph Parisi and optometrist Dr. Scott Han. Both practicing physicians bring expertise in clinical care, patient experience and practice management to the board, as EHA continues to expand as one of the Southeast’s fastest growing, fully integrated eye health networks. Since its formation in March 2018, EHA has increased its network to include 47 providers spanning optical, medical and surgical.Both Dr. Parisi’s and Dr. Han’s practices have been with EHA since the beginning and are critical to its continued success, the company said in a statement. Joseph L. Parisi MD, FRCSC, FACS, serves as medical director and chief ophthalmologist at Clemson Eye in S.C., and has been a practicing ophthalmologist for more than 25 years. Dr. Parisi is certified by the American Board of Ophthalmology and has performed more than 20,000 cataract and refractive surgeries, as well as thousands of microsurgical procedures.Scott B. Han, OD, has been with The Eye Associates in Bradenton, Fla. for 16 years, and serves as a board-certified optometrist and managing partner. With specialties in eye examinations, ocular diseases, medical eyecare and contact lenses, Dr. Han will serve as EHA’s chief optometric officer.“Dr. Han and Dr. Parisi fill a critical gap in our board as practicing physicians with a pulse on what our clinicians need most to run a successful practice,” said Rod Roeser, CEO of Eye Health America. “As we continue to add clinics to our network, both doctors will help our organization make smart business and clinical decisions that improve patient quality and experience.”Eye Health America has seen substantial growth in the past 18 months, and now includes 22 locations, five ambulatory surgical centers, and more than 600 employees. The organization said it plans to continue investing in technology and services that create value for its partners, including patient engagement technology and revenue cycle management.